Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.

L S Kierstead1, E Ranieri, W Olson

  • 1Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

British Journal of Cancer
|December 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue adherence and pressure parameters in vacuum-induced uterine tamponade techniques (Reply to Letter-to-the-Editor).

American journal of obstetrics and gynecology·2026
Same author

Vacuum-induced tamponade using urological catheters for postpartum hemorrhage.

American journal of obstetrics and gynecology·2026
Same author

D-Dimer levels during pregnancy and postpartum: non-applicability of regularly used cut-offs for diagnosis of suspected pulmonary embolism.

Archives of gynecology and obstetrics·2026
Same author

Upgrading a horizontal surface flow constructed wetland with forest waste and aeration.

Journal of environmental management·2025
Same author

Immune signatures underlying post-acute COVID-19 lung sequelae.

Science immunology·2021
Same author

Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: description of an optimized Gel-based protocol.

Journal of biological regulators and homeostatic agents·2021
Same journal

Oligometastatic neuroendocrine tumors: characteristics and prognosis.

British journal of cancer·2026
Same journal

The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.

British journal of cancer·2026
Same journal

Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

British journal of cancer·2026
Same journal

Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

British journal of cancer·2026
Same journal

Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

British journal of cancer·2026
Same journal

De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

British journal of cancer·2026
See all related articles

Researchers identified novel CD4+ T cell epitopes from melanoma-associated antigens. These epitopes are elevated in disease-free melanoma patients and may be useful for cancer vaccines.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • CD4+ T cells are crucial for adaptive immunity, influencing cytotoxic T lymphocyte (CTL) responses and acting as effector cells within the tumor microenvironment.
  • Identifying tumor-specific T cell epitopes is essential for developing effective immunotherapies and cancer vaccines.

Purpose of the Study:

  • To identify tumor epitopes recognized by tumor-reactive human CD4+ T cells.
  • To investigate the frequency and function of these T cells in melanoma patients and healthy donors.

Main Methods:

  • Utilized an HLA-DR4/peptide binding algorithm combined with an IFN-gamma ELISPOT assay.
  • Confirmed/identified CD4+ T cell epitopes from gp100/pmel17 and tyrosinase antigens.
  • Stimulated T cells in vitro using autologous dendritic cells and antigens.

Related Experiment Videos

Main Results:

  • Identified two known and three novel CD4+ T cell epitopes.
  • Observed elevated frequencies of Th1-type CD4+ T cells recognizing these epitopes in HLA-DR4+ melanoma patients who were disease-free post-therapy.
  • Induced epitope-specific CD4+ T cells from normal donors via in vitro stimulation.
  • Demonstrated that peptide-reactive CD4+ T cells recognized HLA-DR4+ melanoma cell lines.

Conclusions:

  • The identified epitopes may serve as vaccine components to enhance Th1-type CD4+ T cell effector function in situ.
  • These findings support the development of T cell-based melanoma vaccines targeting specific epitopes.